Chairs: Jennifer Foltz & John Sunwoo
An update on memory-like NK cells and their use as cancer immunotherapy (124309)
9:20 AM
Translating NK cell biology into the clinic: cells products versus engagers (124310)
9:40 AM
Development and implementation of a universal donor platform for off-the-shelf allogeneic NK cell therapy. (#165)
10:00 AM
Natural Killer cells drive immunotherapy efficacy in Triple-Negative Breast Cancer patients by modulating their transcriptional plasticity (#166)
10:10 AM
Mesothelin CAR memory-like NK cells secreting fusion IL12-A3 cytokine demonstrate enhanced anti-tumor responses in multiple malignancies (#257)
10:20 AM